Blog
RSS FeedPosted by Michael Wonder on 25 Oct 2021
The risks of government negotiation of drug prices
25 October 2021 - Under the guise of Medicare ‘negotiations,’ the US House of Representatives is considering a measure that would ...
Posted by Michael Wonder on 25 Oct 2021
Drug pricing reform opponents win most pharma lobbying money
26 October 2021 - Democratic Party law makers holding up proposed drug pricing reforms are among the largest beneficiaries of the ...
Posted by Michael Wonder on 05 Oct 2021
Pharmaceutical industry backs workplace vaccinations
5 October 2021 - Medicines Australia strongly recommends full COVID-19 vaccinations for the health and safety and protection of all ...
Posted by Michael Wonder on 30 Sep 2021
Medicines industry continues to protect Australians from medicine shortages
30 September 2021 - ACCC extends approval for ongoing collaboration ...
Posted by Michael Wonder on 19 Sep 2021
Manufacturers’ perceptions of the decision-making process for new drug reimbursement in South Korea
17 September 2021 - This study aimed to evaluate manufacturers’ perceptions of the decision-making process for new drug reimbursement and to ...
Posted by Michael Wonder on 09 Sep 2021
MSD Australia endorses new medicines strategic agreement
8 September 2021 - MSD Australia has today welcomed the signing of a new Medicines Strategic Agreement between Medicines Australia ...
Posted by Michael Wonder on 07 Sep 2021
Landmark new medicines agreements to bring significant benefits for Australian patients
7 September 2021 - Australians will have more affordable, improved and guaranteed access to medicines under landmark long-term strategic agreements between ...
Posted by Michael Wonder on 07 Sep 2021
New strategic agreements with the medicines industry
7 September 2021 - The Australian Government has entered into new strategic agreements with Medicines Australia and the Generic and ...
Posted by Michael Wonder on 18 Aug 2021
Pharmaceutical companies should pay for raiding nature's medicine cabinet
11 August 2021 - In 2019, the pharmaceutical industry profited from US$1·2 trillion of global spending on medicines. Most of this ...
Posted by Michael Wonder on 11 Aug 2021
PhRMA’s misleading description of Medicare drug price legislation
10 August 2021 - “They want to repeal a protection in Medicare that protects access to my medicines. They call ...
Posted by Michael Wonder on 10 Aug 2021
What are the obligations of pharmaceutical companies in a global health emergency?
5 August 2021 - During a global health emergency, everyone is morally required to help to combat the disease. ...
Posted by Michael Wonder on 31 Jul 2021
Making pharmaceutical companies report what matters about innovation
29 July 2021 - There is a lack of transparency about the cost of innovation of the pharmaceutical industry even ...
Posted by Michael Wonder on 20 Jul 2021
Pharma CEOs, lobbyists showered Democrat with cash after his attempt to torpedo Pelosi’s drug pricing bill
20 July 2021 - The very next day after Republican Scott Peters attempted to torpedo House Speaker Nancy Pelosi’s signature drug ...
Posted by Michael Wonder on 08 Jul 2021
House report: drug companies spent more on buybacks, dividends than research
8 July 2021 - House Democrats on Thursday released a report that found that the 14 leading drug companies paid ...
Posted by Michael Wonder on 28 Jun 2021
Success rate for marketing authorisation applications from SMEs doubles between 2016 and 2020
28 June 2021 - EMA has published today a report highlighting the Agency’s support for micro, small and medium sized ...